ALB and peripheral arterial disease: In the present study, we utilized this in vivo albumin-labeling tracer 18F-NEB to non-invasively monitor blood perfusion in the early phase post injection (p.i.)as well as the leakage of albumin from the vessel lumen in the late phase p.i. in a mouse PAD model.